[{"NetIncomeLoss_1_Q1_USD":-9435532.0,"StockRedeemedOrCalledDuringPeriodValue_1_Q1_USD":-9603600.0,"Assets_0_Q1_USD":100667493.0,"DueToRelatedPartiesCurrent_0_Q1_USD":10000.0,"ExpenseRelatedToDistributionOrServicingAndUnderwritingFees_1_Q1_USD":2000000.0,"RepaymentsOfRelatedPartyDebt_1_Q1_USD":140591.0,"BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_0_Q1_USD":5000001.0,"TemporaryEquityCarryingAmountAttributableToParent_0_Q1_USD":78410240.0,"AssetsCurrent_0_Q1_USD":637641.0,"InterestIncomeOther_1_Q1_USD":13691.0,"CommitmentsAndContingencies_0_Q1_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":8625000.0,"PreferredStockSharesOutstanding_0_Q1_shares":null,"ProceedsFromRelatedPartyDebt_1_Q1_USD":52627.0,"Liabilities_0_Q1_USD":17257243.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":513059.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0084,"FairValueAdjustmentOfWarrants_1_Q1_USD":8955424.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-87964.0,"BusinessAcquisitionPercentageOfVotingInterestsAcquired_0_Q1_pure":0.5,"SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_0_Q1_shares":7841024.0,"FederalDepositInsuranceCorporationPremiumExpense_1_Q1_USD":250000.0,"BusinessAcquisitionCostOfAcquiredEntityTransactionCosts_0_Q1_USD":4197388.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.244,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.0001,"OperatingIncomeLoss_1_Q1_USD":-493818.0,"OtherNonoperatingExpense_1_Q1_USD":317023.0,"InvestmentIncomeInterest_1_Q1_USD":13691.0,"PreferredStockSharesIssued_0_Q1_shares":null,"OtherUnderwritingExpense_1_Q1_USD":2000000.0,"ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_0_Q1_USD":0.01,"AdditionalPaidInCapital_0_Q1_USD":13015395.0,"NonoperatingIncomeExpense_1_Q1_USD":-8941714.0,"AccountsPayableCurrent_0_Q1_USD":5000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_1_Q1_USD":-581702.0,"LiabilitiesCurrent_0_Q1_USD":135647.0,"OtherCostAndExpenseOperating_1_Q1_USD":329713.0,"MarketableSecuritiesNoncurrent_0_Q1_USD":100029852.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-493738.0,"PrepaidExpenseCurrent_0_Q1_USD":124582.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":19.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-8015887.0,"IncreaseDecreaseInDueToRelatedParties_1_Q1_USD":-24334.0,"StockholdersEquity_0_Q1_USD":5000010.0,"DeferredOfferingCosts_0_Q1_USD":329713.0,"ProfitLoss_1_Q1_USD":-9435532.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.2,"SharePrice_0_Q1_USD":10.0,"PreferredStockSharesAuthorized_0_Q1_shares":1000000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":100667493.0,"PreferredStockValue_0_Q1_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"MarketableSecurities_0_Q1_USD":100029852.0,"IncreaseDecreaseInPrepaidExpense_1_Q1_USD":-24395.0,"Ticker":"HUMA","CIK":"1818382","name":"ALPHA HEALTHCARE ACQUISITION CORP.","OfficialName":"Humacyte Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"762233833.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210517"}]